Globus Medical, Inc. (GMED) Reports Revenue Well Above Consensus, Brean Capital Note; PT to $33
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Globus Medical Reports First Quarter 2015 Results
May 5, 2015 4:10 PM EDTAUDUBON, Pa.--(BUSINESS WIRE)-- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the first quarter ended March 31, 2015.
Worldwide sales increased 15.2% to $131.6 million, or 16.4% on a constant currency basis Net income increased 16.6% to $24.6 million Fully diluted earnings per share (EPS) were $0.26 Non-GAAP Adjusted EBITDA was 35.2% of sales Company increases 2015 guidance for sales to $514 million and EPS to $1.02David Paul,... More
